Metraipolis › archive › dc_4c84a61978ee

Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trial — Europe PMC PMID:42426223

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42426223
DOI
10.1038/s41591-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-10-18T09:42:54.080Z
SHA-256 of the archived text
9cbab04985b8e8b73f4871367aba1ee3a43164540760832601bece0333b45f2c
Stable URL of this page
https://metraipolis.com/documento/dc_4c84a61978ee

How to cite

Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trial — Europe PMC PMID:42426223 — Europe PMC (en), https://europepmc.org/article/MED/42426223 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4c84a61978ee (Metraipolis archive dc_4c84a61978ee, sha256 9cbab04985b8e8b73f4871367aba1ee3a43164540760832601bece0333b45f2c)
BibTeX
@misc{dc4c84a61978ee,
  title = {Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trial — Europe PMC PMID:42426223},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42426223},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4c84a61978ee; sha256 9cbab04985b8e8b73f4871367aba1ee3a43164540760832601bece0333b45f2c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42426223. Agents can read the archived copy with the MCP tool read_document.